ロード中...
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
p53 alterations are considered to be predictive of poor prognosis in hepatocellular carcinoma (HCC) and may induce a humoral response. Anti-p53 serum antibodies were assessed by enzyme-linked immunosorbent assay (ELISA) using purified recombinant human p53 on 130 European HCC patients before treatme...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362420/ https://ncbi.nlm.nih.gov/pubmed/10027337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690095 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|